2023 NLA Scientific Sessions Abstracts
Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience.
Efficacy and safety of evinacumab in pediatric patients with homozygous familial hypercholesterolemia
Presenting Author: Albery Wiegman
Authors: Albert Wiegman, Susanne Greber-Platzer, Shazia Ali, Divya Singh, M. Doortje Reijman, Eliot A Brinton, Min-Ji Charng, Shubha Srinivasan, Carissa Baker-Smith, Seth Baum, Julie Brothers, Jacob Hartz, Patrick M. Moriarty, Poulabi Banerjee, Richard T George, Robert Pordy
A Randomized Study to Compare LDL-C Lowering Effects of Inclisiran With Usual Care vs Usual Care Alone in Patients With Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION Trial
Presenting Author: Jeffrey L. Anderson
Authors: Ann Marie Navar, Neerja Balachander, Jason LeCocq, Nihar R Desai, Kirk U Knowlton
Prevalence of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease
Presenting Author: Robert Block
Authors: Bhavana Upadhyaya, Ying Wang, Jeffrey Bruckel M.D., M.P.H., Robert C. Block M.D., M.P.H.
Evinacumab reduces US apheresis eligibility in patients with homozygous familial hypercholesterolemia
Presenting Author: Robert Pordy
Authors: Frederick J. Raal, Robert S. Rosenson, Patrick M. Moriarty, Shazia Ali Poulabi Banerjee, Jian Zhao, Richard T. George, Jennifer McGinniss, Robert Pordy
A genome-first approach to identify carriers of Familial Hypercholesterolemia-causing variants